Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Raymond James Human Health Innovation Conference
 Monday, June 21, 2021
 12:40pm EDT